AI-based bioinformatics algorithms with utility in cancer classification for improved accuracy in cancer diagnosis, prognosis and therapy management
Heidelberg Epignostix has raised €4.3M across 1 funding round from 4 investors, most recently a round in Jul 2024. Based in Heidelberg, Germany; active in Healthtech. Data as of 6 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2024-07-02 | Other |
| €4.3M |
| Carma Fund,BW Seed Fonds,High-Tech Gründerfonds (HTGF),LBBW Venture Capital GmbH |
| View deal → |
